Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study J. Gonçalves-Pereira,

Thirty-day mortality of nosocomial systemic bacterial infections according to antibiotic susceptibility in an 800-bed teaching hospital in France D.

L. S. Tzouvelekis, A. Markogiannakis, E. Piperaki, M. Souli, G. L

L. Boyanova Clinical Microbiology and Infection

Hospitalization in double-occupancy rooms and the risk of hospital-acquired influenza: a prospective cohort study E. Munier-Marion, T. Bénet, C. Régis,

C.N. van Ettekoven, D. van de Beek, M.C. Brouwer

I.J. Schalk Clinical Microbiology and Infection

Hospitalization in double-occupancy rooms and the risk of hospital-acquired influenza: a prospective cohort study E. Munier-Marion, T. Bénet, C. Régis,

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis T. Steinmetz, N.

Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications T.-L. Liao, Y.-M.

Migrant health—a cause for concern?

Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010–2011): assessment of clinical practice.

Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics Y.H. van Beurden, S. Nezami,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

P. Vironneau, R. Kania, P. Herman Clinical Microbiology and Infection

Refugee crisis and re-emergence of forgotten infections in Europe

Paradoxical immune reconstitution inflammatory syndrome associated with cryptococcal meningitis in China: a 5-year retrospective cohort study S. Yan,

Treatment of complicated skin and skin structure infections in areas with low incidence of antibiotic resistance—a retrospective population based study.

Impact of inadequate initial antimicrobial therapy on mortality in patients with bacteraemic cholangitis: a retrospective cohort study Y. Tagashira,

A. F. Simonetti, C. Garcia-Vidal, D. Viasus, D. García-Somoza, J

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Dermatitis by Dermatophilus congolensis

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Trends in length of stay, mortality and readmission among patients with community- acquired bacteraemia M. Søgaard, R.W. Thomsen, R.B. Bang, H.C. Schønheyder,

M. Nørgaard, H. Larsson, G. Pedersen, H.C. Schønheyder, H.T. Sørensen

Pre-transplant thymic function is associated with the risk of cytomegalovirus disease after solid organ transplantation I. Gracia-Ahufinger, S. Ferrando-Martínez,

Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study J. Gonçalves-Pereira,

Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit.

Vector control: a cornerstone in the malaria elimination campaign

Comparison of respiratory virus shedding by conventional and molecular testing methods in patients with haematological malignancy L. Richardson, J. Brite,

Y. Maor, N. Belausov, D. Ben-David, G. Smollan, N. Keller, G. Rahav

C. Garcia-Vidal, I. Sanchez-Rodriguez, A. F. Simonetti, J. Burgos, D

Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients

Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis J. Jung, M.Y. Kim, H.J. Lee, Y.S. Park, S.-O.

G. Höffken Clinical Microbiology and Infection

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit E. Theocharidou, B. Agarwal, G. Jeffrey,

Metagenomics and probiotics

Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study J.-Y. Feng, S.-F. Huang, W.-Y. Ting, Y.-C.

Previously unknown species of Aspergillus

Long-term mortality following bloodstream infection

Fatal cytomegalovirus pneumonia in patients with haematological malignancies: an autopsy-based case–control study H.A. Torres, E. Aguilera, A. Safdar,

Systematic review of antibiotic consumption in acute care hospitals

Combination antimicrobial therapy in patients with Staphylococcus aureus bacteraemia—a post hoc analysis in 964 prospectively evaluated patients S. Rieg,

Impact of Candida spp. isolation in the respiratory tract in patients with intensive care unit-acquired pneumonia S. Terraneo, M. Ferrer, I. Martín-Loeches,

M. Daudin, P. Tattevin, B. Lelong, E. Flecher, S. Lavoué, C. Piau, A

Current experience in treating invasive zygomycosis with posaconazole

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS M. Rybicka,

Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patients N. Gianotti,

Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013 A. Badura, G. Feierl, G. Pregartner,

Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices? G.N. Pongas, R.E.

Survival of rhinoviruses on human fingers

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

J.L. Balcázar Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection A. Russo, M. Falcone, M. Fantoni, R. Murri,

Presentation transcript:

Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis A. Kyvernitakis, H.A. Torres, Y. Jiang, G. Chamilos, R.E. Lewis, D.P. Kontoyiannis Clinical Microbiology and Infection Volume 22, Issue 9, Pages 811.e1-811.e8 (September 2016) DOI: 10.1016/j.cmi.2016.03.029 Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Annual incidence and deaths from mucormycosis in patients with haematologic malignancies. Clinical Microbiology and Infection 2016 22, 811.e1-811.e8DOI: (10.1016/j.cmi.2016.03.029) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 2 Propensity score–adjusted survival curves for patients with haematologic malignancies and mucormycosis treated with monotherapy or combination treatment (p 0.71). Clinical Microbiology and Infection 2016 22, 811.e1-811.e8DOI: (10.1016/j.cmi.2016.03.029) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 3 Kaplan-Meier survival curves according to assigned mortality risk scores for patients with haematologic malignancies and mucormycosis treated with monotherapy or combination treatment. Shown are data from patients at low risk for mortality (risk score, <33; p 0.78) and patients at high risk for mortality (risk score, >33; p 0.35). Clinical Microbiology and Infection 2016 22, 811.e1-811.e8DOI: (10.1016/j.cmi.2016.03.029) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2016 22, 811. e1-811. e8DOI: (10 Clinical Microbiology and Infection 2016 22, 811.e1-811.e8DOI: (10.1016/j.cmi.2016.03.029) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions